I've been thinking about deprenyl for some time. I have motivational problems related to inattentive ADD, which have only been exacerbated by years of dealing with a fairly severe chronic pain situation, and the attendant limitations it imposes on me.
I'm currently taking tramadol, 100mg 2-3x daily (for about 2 years now). Tramadol is an SNRI, and also a weak SSRI. This is theoretically counterindicated because of deprenyl's MAOI quality. But several people have mentioned in passing that combining this with deprenyl should not be a problem (luv2increase used to use this combo), but I was hoping for a more solid understanding.
If problems were to arise, would they necessarily be subjectively apparent? In what timeframe would they occur (i.e. could something really bad happen before there was a chance to notice/do anything about it)?
What difference does MAOI A/B make in this situation? Would deprenyl be safe as long as I remained under the doses which putatively cause MAO-A inhibition (~10mg)?
I'm also looking at BPAP (deprenyl's tryptamine analog), which is a very weak MAO-A inhibitor: "(-)BPAP, obviously because of its close structural similarity to tryptamine, is a weak, selective inhibitor of MAO-A, but this effect is from pharmacological point of view not significant. The effect of (-)BPAP in the shuttle box is due exclusively to its CAE effect, as this substance is 10 times more potent than clorgyline in antagonizing tetrabenazine induced depression, while 10,000 times less potent than clorgyline in inhibiting MAO-A activity" (Knoll 2003). Would this be better than deprenyl because of the "pharmacological insignificance" of the inhibition, or worse because it's MAOI-A?
I would warmly appreciate any help you could offer in understanding the practical risks of this combo more specifically, and how experimentation might be conducted safely.
Edited by chrono, 16 May 2010 - 11:13 AM.